Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STEL
1151
DELISTED
Stellar Bancorp
STEL
| $11.3M | 0.02% |
348,718
-31,298
| -8% | -$1.01M |
|
1152
CALL
Boston Scientific
BSX
$69B
| $11.3M | 0.02% |
+295,000
| New | +$11.3M |
|
1153
Box
BOX
$4.38B
| $11.3M | 0.02% |
584,538
-612,150
| -51% | -$12.7M |
|
1154
Protagonist Therapeutics
PTGX
$8.7B
| $11.2M | 0.02% |
893,155
+203,004
| +29% | +$1.79M |
|
|
SIX
1155
DELISTED
Six Flags Entertainment Corp.
SIX
| $11.2M | 0.02% |
227,438
-541,666
| -70% | -$30.6M |
|
1156
Greif
GEF
$4.72B
| $11.2M | 0.02% |
271,554
+112,100
| +70% | +$4.48M |
|
|
AXNX
1157
DELISTED
Axonics, Inc. Common Stock
AXNX
| $11.2M | 0.02% |
467,250
-331,700
| -42% | -$6.02M |
|
1158
CALL
Baxter International
BAX
$12.5B
| $11.1M | 0.02% |
+137,100
| New | +$9.98M |
|
|
FNSR
1159
DELISTED
Finisar Corp
FNSR
| $11.1M | 0.02% |
+481,095
| New | +$11M |
|
1160
Ecolab
ECL
$79.9B
| $11.1M | 0.02% |
+63,113
| New | +$10.3M |
|
1161
iShares MSCI Germany ETF
EWG
$1.56B
| $11.1M | 0.02% |
413,812
+359,606
| +663% | +$9.61M |
|
|
ADAP
1162
DELISTED
Adaptimmune Therapeutics
ADAP
| $11.1M | 0.02% |
2,588,740
+490,468
| +23% | +$2.28M |
|
|
VGR
1163
DELISTED
Vector Group Ltd.
VGR
| $11.1M | 0.02% |
1,527,119
-1,305,698
| -46% | -$9.71M |
|
1164
IBM
IBM
$215B
| $11.1M | 0.02% |
82,347
+28,431
| +53% | +$3.62M |
|
1165
PUT
Edwards Lifesciences
EW
$48.1B
| $11.1M | 0.02% |
174,000
+129,000
| +287% | +$7.36M |
|
1166
AAR Corp
AIR
$5.56B
| $11.1M | 0.02% |
+340,261
| New | +$12.3M |
|
1167
Yext
YEXT
$568M
| $11.1M | 0.02% |
505,787
+189,736
| +60% | +$3.44M |
|
|
CZR
1168
DELISTED
Caesars Entertainment Corporation
CZR
| $11M | 0.02% |
1,271,319
+842,726
| +197% | +$7.31M |
|
1169
Televisa
TV
$1.48B
| $11M | 0.02% |
997,645
+531,500
| +114% | +$6.31M |
|
|
AZUL
1170
DELISTED
Azul
AZUL
| $11M | 0.02% |
377,442
+94,492
| +33% | +$2.82M |
|
|
JBGS
1171
JBG SMITH
JBGS
$846M
| $11M | 0.02% |
266,515
+212,300
| +392% | +$8.33M |
|
1172
Altria Group
MO
$125B
| $11M | 0.02% |
191,782
-86,081
| -31% | -$4.4M |
|
|
HSKA
1173
DELISTED
Heska Corp
HSKA
| $11M | 0.02% |
129,399
+110,740
| +593% | +$9.99M |
|
|
MRTX
1174
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $11M | 0.02% |
+150,000
| New | +$10.2M |
|
1175
Huntington Ingalls Industries
HII
$11.6B
| $11M | 0.02% |
53,006
-8,411
| -14% | -$1.72M |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.